CVRx, Inc. - Common Stock, $0.01 par value (CVRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
CVRX on Nasdaq
Shares outstanding
26,135,461
Price per share
$7.01
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
15,199,333
Total reported value
$107,921,876
% of total 13F portfolios
0%
Share change
+223,084
Value change
+$1,343,918
Number of holders
89
Price from insider filings
$7.01
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JOHNSON & JOHNSON 15% $28,578,928 4,024,861 JOHNSON & JOHNSON 31 Dec 2025
NEW ENTERPRISE ASSOCIATES 10 L P 7.8% $13,635,539 2,026,083 New Enterprise Associates 10, Limited Partnership 18 Feb 2025
Vensana Capital I GP, LLC 7.2% $11,849,740 1,760,734 Kirk Nielsen 31 Dec 2024
Cooperatieve Gilde Healthcare IV U.A. 4.9% $8,287,928 1,231,490 Cooperatieve Gilde Healthcare IV U.A. 04 Feb 2025

As of 31 Dec 2025, 89 institutional investors reported holding 15,199,333 shares of CVRx, Inc. - Common Stock, $0.01 par value (CVRX). This represents 58% of the company’s total 26,135,461 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) together control 55% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JOHNSON & JOHNSON 15% 4,024,861 -1.9% 5.2% $28,576,513
NEA Management Company, LLC 7.8% 2,026,083 0% 0.73% $14,385,189
VANGUARD GROUP INC 4.3% 1,120,663 +2.8% 0% $7,956,707
BlackRock, Inc. 4.1% 1,061,087 +4.5% 0% $7,533,717
GSK plc 3.9% 1,007,583 0% 0.9% $7,153,839
Balyasny Asset Management L.P. 3.1% 814,943 +17% 0.01% $5,786,095
SILVERCREST ASSET MANAGEMENT GROUP LLC 2.4% 634,639 +77% 0.03% $4,505,937
Parkman Healthcare Partners LLC 1.6% 413,018 -16% 0.28% $2,932,428
GEODE CAPITAL MANAGEMENT, LLC 1.5% 403,949 -0.25% 0% $2,869,069
MORGAN STANLEY 1.5% 380,641 -12% 0% $2,702,551
STATE STREET CORP 1.2% 311,658 +5.5% 0% $2,212,772
CITADEL ADVISORS LLC 1.2% 305,503 +563% 0% $2,169,071
JANE STREET GROUP, LLC 0.86% 225,349 +215% 0% $1,599,978
GSA CAPITAL PARTNERS LLP 0.7% 183,531 -17% 0.11% $1,303,000
FourWorld Capital Management LLC 0.69% 180,000 +24% 1.2% $1,278,000
GOLDMAN SACHS GROUP INC 0.68% 177,598 -12% 0% $1,260,946
TUDOR INVESTMENT CORP ET AL 0.6% 157,260 +25% 0.01% $1,116,546
MAIRS & POWER INC 0.55% 142,456 -1.7% 0.01% $1,011,438
MILLENNIUM MANAGEMENT LLC 0.53% 139,202 -39% 0% $988,334
NORTHERN TRUST CORP 0.53% 137,809 -7.7% 0% $978,445
D. E. Shaw & Co., Inc. 0.37% 96,212 +26% 0% $683,105
UBS Group AG 0.34% 88,401 -42% 0% $627,647
Quantinno Capital Management LP 0.29% 75,973 +13% 0% $539,408
Cresset Asset Management, LLC 0.27% 71,802 0% 0% $509,794
AlphaQuest LLC 0.27% 70,795 +734% 0.03% $502,645

Institutional Holders of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 15,199,333 $107,921,876 +$1,343,918 $7.10 89
2025 Q3 14,003,450 $113,001,810 -$4,140,662 $8.07 91
2025 Q2 14,566,804 $85,403,778 -$19,986,146 $5.88 91
2025 Q1 15,971,769 $195,337,855 +$10,778,190 $12.23 95
2024 Q4 15,154,273 $192,128,165 +$11,666,171 $12.67 91
2024 Q3 14,208,138 $125,172,924 +$5,810,039 $8.81 84
2024 Q2 13,192,379 $158,176,281 -$11,196,197 $11.99 72
2024 Q1 13,441,680 $244,665,057 +$21,036,083 $18.21 87
2023 Q4 12,015,323 $377,446,209 +$6,898,602 $31.44 83
2023 Q3 11,953,961 $181,343,253 +$2,863,854 $15.17 64
2023 Q2 11,594,427 $179,048,989 +$23,946,250 $15.44 66
2023 Q1 10,400,213 $96,928,042 -$20,701,454 $9.32 61
2022 Q4 10,299,118 $188,989,468 +$3,540,115 $18.35 48
2022 Q3 10,529,611 $98,240,851 -$6,931,505 $9.33 37
2022 Q2 10,888,954 $65,444,210 -$7,076,705 $6.01 34
2022 Q1 12,073,187 $72,317,176 -$14,166,594 $5.99 55
2021 Q4 12,884,491 $157,579,777 -$25,347,085 $12.23 53
2021 Q3 11,758,612 $194,426,346 -$15,245,912 $16.54 49
2021 Q2 13,787,189 $386,044,000 +$386,044,000 $28.00 59